Clinical Trials Directory

Trials / Completed

CompletedNCT02456961

Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin

Comparative Study of Results of Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin: a Randomized Control Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
Ufa Eye Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The standard CXL technique involves removal of the epithelium to enable riboflavin to penetrate into stromal tissue, to avoid epithelial debridement and increasing the patient's comfort and safety transepithelial corneal crosslinking (CXL) was suggested. Iontophoresis of riboflavin is one of approach for riboflavin impregnation. In this study, the investigators compared the results of standard corneal crosslinking (CXL) and transepithelial CXL via iontophoresis of riboflavin after 24 months follow up.

Conditions

Interventions

TypeNameDescription
PROCEDUREiontophoresis of riboflavin
PROCEDUREepithelium-off
PROCEDURECorneal collagen crosslinkingStandard surface UVA irradiation (370 nm, 3 mW/cm2; UFalink, Russian Federation) was then applied at a 5-cm distance for 30 minutes. During UVA exposure, hypotonic riboflavin drops were continued every 2 minutes.
DEVICEgalvanizator, Potok-1Device for providing iontophoresis procedure
DRUGDextralinkRiboflavin 0,1% + Dextran T-500
DRUGRiboflavin 0,1%
DEVICEUFalinkdevice for UVA irradiation - providing UVA light - 370 nm, 3 mW/cm2

Timeline

Start date
2010-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2015-05-29
Last updated
2015-05-29

Source: ClinicalTrials.gov record NCT02456961. Inclusion in this directory is not an endorsement.